BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 19, 2007
View Archived Issues
NeuroSearch Shares Boosted By Tesofensine Obesity Data
Shares in NeuroSearch A/S gained almost 22 percent Monday on news that its candidate obesity drug tesofensine attained an average weight reduction of about 10 ten percent in a Phase IIb clinical trial. (BioWorld International)
Read More
Ganymed Adds To Series C; Closes 37.2M Financing Round
No Abstract
Read More
Gene Expression Levels Vary At Higher Levels Than Thought
Read More
Oxford BioMedica Using Sanofi Deal As Catalyst For Growth
Read More
European Industry Seeks Wider Links In Orphan Drug Programs
Read More
Other News To Note
Read More
Renovo Reports Positive Data From Phase IIb Trial Of Juvista
Read More
Mutabilis, Oroxcell Collaborate On Preclinical Antibiotic Agent
Read More
EU Commissioner Defends Rule Banning GM-Free Zones
Read More